Abstract
Together with hypertension and dyslipidemia, diabetes is an important conventional risk factor for vascular events, including stroke. The prevalence of diabetes has increased dramatically worldwide, and its importance has increased. Diabetes is a prognosticator that influences both the incidence and recurrence of stroke and functional outcome and survival poststroke. Therefore, it is critical to diagnose diabetes as early as possible from the initial hospitalization and to maintain normoglycemia appropriately. During the chronic stage of stroke, the principles of diabetes management are not different from those for diabetes without stroke. Although numerous antidiabetic agents have been developed in recent years, it is difficult for stroke physicians to completely understand the therapeutic principles. In this chapter, we will guide you through the essence of diabetes management during the acute and chronic stages of stroke.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Luitse MJ, Biessels GJ, Rutten GE, et al. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11:261–71.
Kruyt ND, Biessels GJ, Devries JH, et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6:145–55.
Kim BJ, Lee SH, Kang BS, et al. Diabetes increases large artery diseases, but not small artery diseases in the brain. J Neurol. 2008;255:1176–81.
Schulz UG, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke. 2003;34:2050–9.
American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11–24.
Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.
Mccormick MT, Muir KW, Gray CS, et al. Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke. 2008;39:2177–85.
Mcdonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am. 2012;41:175–201.
Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–32.
Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397–406.
Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Lee, SH., Kang, DW. (2017). Diabetes Management After Stroke. In: Lee, SH. (eds) Stroke Revisited: Diagnosis and Treatment of Ischemic Stroke. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1424-6_25
Download citation
DOI: https://doi.org/10.1007/978-981-10-1424-6_25
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1423-9
Online ISBN: 978-981-10-1424-6
eBook Packages: MedicineMedicine (R0)